Formulation and evaluation nasal insulin gel

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue 3, 2010, Pages 161-164

  Vamshi Krishna, T ^a   Madhusudan Rao, Y ^b  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b KAKATIYA UNIVERSITY   (India)

Author keywords

Insulin; Nasal route of administration

Indexed keywords

CHITOSAN; GLUCOSE; INSULIN; NEUTRAL INSULIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; EVALUATION; GEL; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; NONHUMAN; NOSE CAVITY; RABBIT;

EID: 77954734452     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jaleh Varshosaz, Hassan Sadrai, Alireza Heidari, 2006. Nasal Delivery of Insulin using Bioadhesive Chitosan Gels; Drug Delivery, 13, 31-38.
2. Reshma D' Souza, Srinivas Mutalik, Sudha Vidyasagar, Madhavacharya Venkatesh, Nayanabhirama Udupa, 2005. Nasal insulin gel as an alternate to parenteral insulin, AAPS PharmSciTech, 6(2), Article 27.
3. Abdol Hossein Najefabadi, Payam Moslemi, Hosnieh Tajerzadeh, 2004. Intranasal bioavailability of insulin from carbopol based gel spray in rabbit; Drug Delivery, 11,295-300.
4. Chein, Y. W, Su, K. S. E, Chang, S.F, 1989. Nasal systemic drug delivery, Dekker, 1-77.
5. William, T. Cefalu, MD, 2004. Concept, strategies and feasibility of non invasive insulin delivery, Diabetes Care 27:239-246.
6. Thanou, M, Verhoef, J. C, Junginger, H. E, 2001. Oral drug absorption enhancement by chitosan and its derivatives, Adv. Drug Delivery, 52, 117-126.
7. Heinemann, L, Pfutzner, A, Heise, T, 2001. Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery. Curr Pharm Res 7:1327-1351.
8. Dodane, V, Amin Khan, M, Merwin, J. R, 1999. Effect of chitosan on epithelial permeability and structure, Int. J. Pharm. 182 21- 32.
9. Beht.et al, 1998. Optimization of systemic nasal drug delivery with pharmaceutical excipients, Adv. Drug. Del. Rev, 29, 117- 133
10. Kadam, S.S, Mahadik, K.R, Pawar, A.P, Paradkar, A.R, 1993. Transnasal delivery of peptides - a review, The East Pharm, 47 - 49.
11. Lee, W. A, Narog, B.A, Patapoff T. W, Wang, Y.J, 1991. Intranasal bioavailability of insulin powder formulation: Effect of permeation enhancer to protein ratio, J. Pharm. Sci. 80, 725- 729.
12. Schipper.et al, 1991. The nasal mucociliary clearance: relevance to nasal drug delivery" Pharma. Res., 7, 807-814.